Comment by cassepipe

I am sympathetic to your claim but after reading the article it does seem to be a case of overregulation, or lack of flexibility at least. Could you use the examples of the article in order to illustrate how this is bad regulatation rather than overregulation ?

To go in the direction of your claim, hasn't the FDA model often been criticized for how easy it is to comply with for medical devices/complements ?